Value-Based Healthcare in Urology: A Collaborative Review.

[1]  M. Mcclellan,et al.  Building A Better Health Care System Post-Covid-19: Steps for Reducing Low-Value and Wasteful Care , 2020, Nejm Catalyst Innovations in Care Delivery.

[2]  P. Mariappan,et al.  Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme. , 2020, European urology.

[3]  D. Lewis,et al.  Simulating the impact of centralization of prostate cancer surgery services on travel burden and equity in the English National Health Service: A national population based model for health service re‐design , 2020, Cancer medicine.

[4]  A. Navathe,et al.  The Impact Of Bundled Payment On Health Care Spending, Utilization, And Quality: A Systematic Review. , 2020, Health affairs.

[5]  A. Luckenbaugh,et al.  Trends in the Cost of Cancer Care: Beyond Drugs. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  K. Bozic,et al.  A Review of Bundled Payments in Total Joint Replacement. , 2019, JBJS reviews.

[7]  C. Booth,et al.  Effect of centralization on complex surgical care: A population-based case study of radical cystectomy. , 2019, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[8]  Tyler R. McClintock,et al.  Time-Driven Activity-Based Costing in Urologic Surgery Cycles of Care. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[9]  A. Gavin,et al.  Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. , 2019, The Lancet. Oncology.

[10]  R. Crump,et al.  A new model for delivering care for lower urinary tract symptoms. , 2018, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[11]  Z. Čizmić,et al.  The Historical Development of Value-Based Care: How We Got Here , 2018, The Journal of bone and joint surgery. American volume.

[12]  T. Feeley,et al.  Transitioning Payment Models: Fee-for-Service to Value-Based Care , 2018 .

[13]  S. Siesling,et al.  Centralisation of cancer surgery and the impact on patients' travel burden. , 2018, Health policy.

[14]  J. Catto,et al.  Health-related quality of life after treatment for bladder cancer in England , 2018, British Journal of Cancer.

[15]  M. Barclay,et al.  Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000–2010 , 2018, BJU international.

[16]  David C. Miller,et al.  System-Level Health-Care Integration and the Costs of Cancer Care Across the Disease Continuum. , 2018, Journal of oncology practice.

[17]  N. James,et al.  Centralisation of radical cystectomies for bladder cancer in England, a decade on from the ‘Improving Outcomes Guidance’: the case for super centralisation , 2018, BJU international.

[18]  A. Laviana,et al.  Time‐Driven Activity‐Based Costing Analysis of Urological Stone Disease , 2017, Urology practice.

[19]  T. Showalter,et al.  Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy. , 2018, Brachytherapy.

[20]  David C. Miller,et al.  Episode-based Payment Variation for Urologic Cancer Surgery. , 2018, Urology.

[21]  David C. Miller,et al.  Association of Delivery System Integration and Outcomes for Major Cancer Surgery , 2018, Annals of Surgical Oncology.

[22]  UsawachintachitManint,et al.  Defining the Costs of Reusable Flexible Ureteroscope Reprocessing Using Time-Driven Activity-Based Costing , 2017 .

[23]  David C. Miller,et al.  Alternative payment models and urology , 2017, Current opinion in urology.

[24]  David C. Miller,et al.  Collaborative quality improvement , 2017, Current opinion in urology.

[25]  Kenneth D. Mandl,et al.  A 21st-Century Health IT System - Creating a Real-World Information Economy. , 2017, The New England journal of medicine.

[26]  A. Partin,et al.  Implementation of a Surgeon‐Level Comparative Quality Performance Review to Improve Positive Surgical Margin Rates during Radical Prostatectomy , 2017, The Journal of urology.

[27]  F. Gaylis,et al.  White Paper on MACRA: Past, Present and Future , 2017 .

[28]  G. Cooper,et al.  Publicly Available Outcome Data for Individual Surgeons: Lessons from Cardiac Surgery. , 2017, European urology.

[29]  E. Mayer,et al.  Where are we with improving outcome guidance? An update on pelvic urological services in the NHS , 2017 .

[30]  S. McPhail,et al.  Trends in incidence, mortality and treatment of penile cancer before and after centralisation of penile cancer services in England (1990–2009) , 2017 .

[31]  D. Kapoor,et al.  The LUGPA Alternative Payment Model for Initial Therapy of Newly Diagnosed Patients With Organ-confined Prostate Cancer: Rationale and Development. , 2017, Reviews in urology.

[32]  A. Darves-Bornoz,et al.  The evolution of financial incentives in the U.S. health care system. , 2017, Urologic oncology.

[33]  David C. Miller,et al.  Health Care Integration and Quality among Men with Prostate Cancer , 2017, The Journal of urology.

[34]  K. Bozic,et al.  Value-based Healthcare: Part 2—Addressing the Obstacles to Implementing Integrated Practice Units for the Management of Musculoskeletal Disease , 2016, Clinical orthopaedics and related research.

[35]  David C. Miller,et al.  Identifying Drivers of Episode Cost Variation With Radical Prostatectomy. , 2016, Urology.

[36]  David C. Miller,et al.  Implications of evolving delivery system reforms for prostate cancer care. , 2016, The American journal of managed care.

[37]  Jim C Hu,et al.  Determining the True Costs of Treating Small Renal Masses Using Time Driven, Activity Based Costing , 2016, Urology practice.

[38]  M. Porter,et al.  Value-based healthcare: implications for thyroid cancer , 2016 .

[39]  H. Kuerer,et al.  Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes , 2016, Annals of Surgical Oncology.

[40]  J. Witjes,et al.  Economic Burden of Bladder Cancer Across the European Union. , 2016, European urology.

[41]  P. Cucchiara,et al.  Achieving Value in Primary Care: The Primary Care Value Model , 2016, The Annals of Family Medicine.

[42]  William Hsu,et al.  Utilizing time‐driven activity‐based costing to understand the short‐ and long‐term costs of treating localized, low‐risk prostate cancer , 2015, Cancer.

[43]  R. Young.  Value-Based Cancer Care. , 2015, The New England journal of medicine.

[44]  T. D. de Reijke,et al.  Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach. , 2015, European urology.

[45]  J. Kelly,et al.  Achieving Quality Assurance of Prostate Cancer Surgery During Reorganisation of Cancer Services. , 2015, European urology.

[46]  D. Gillatt,et al.  Trends in operative caseload and mortality rates after radical cystectomy for bladder cancer in England for 1998-2010. , 2015, European urology.

[47]  John T. Wei,et al.  Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic , 2015, Cancer.

[48]  Steven J Frank,et al.  Defining a standard set of patient-centered outcomes for men with localized prostate cancer. , 2014, European urology.

[49]  K. Chamie,et al.  Measuring the cost of care in benign prostatic hyperplasia using time-driven activity-based costing (TDABC). , 2015, Healthcare.

[50]  Whitney Murphy,et al.  Optimizing value utilizing Toyota Kata methodology in a multidisciplinary clinic. , 2014, Journal of pediatric urology.

[51]  T. Schlomm,et al.  Improving outcome of surgical procedures is not possible without adequate quality measurement. , 2014, European urology.

[52]  T. Skolarus,et al.  Regional variation in quality of prostate cancer care. , 2014, The Journal of urology.

[53]  C. Morash,et al.  Piloting a regional collaborative in cancer surgery using a "community of practice" model. , 2013, Current oncology.

[54]  N. Clarke,et al.  Should centralized histopathological review in penile cancer be the global standard? , 2013, BJU international.

[55]  A. D'Amico,et al.  Models of care and NCCN guideline adherence in very-low-risk prostate cancer. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[56]  Jean M. Mitchell.  Urologists' use of intensity-modulated radiation therapy for prostate cancer. , 2013, The New England journal of medicine.

[57]  M. Porter,et al.  The Strategy That Will Fix Health Care , 2013 .

[58]  T. Guzzo,et al.  Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns. , 2013, The Journal of urology.

[59]  F. Vicini,et al.  Impact of a Prostate Multidisciplinary Clinic Program on Patient Treatment Decisions and on Adherence to NCCN Guidelines: The William Beaumont Hospital Experience , 2013, American journal of clinical oncology.

[60]  M. Porter,et al.  Redesigning primary care: a strategic vision to improve value by organizing around patients' needs. , 2013, Health affairs.

[61]  J. Gore,et al.  Hospital‐level variation in the quality of urologic cancer surgery , 2012, Cancer.

[62]  James G Wright,et al.  Value-Based Healthcare and Orthopaedic Surgery: Editorial Comment , 2012, Clinical orthopaedics and related research.

[63]  Anthony J. Culyer,et al.  The NICE Cost-Effectiveness Threshold , 2012, PharmacoEconomics.

[64]  H. Storm,et al.  Improved survival of Danish cancer patients 2007-2009 compared with earlier periods. , 2011, Danish medical bulletin.

[65]  M. Porter,et al.  The Big Idea : How to Solve the Cost Crisis in Health Care , 2012 .

[66]  A. Haese*,et al.  Full functional-length urethral sphincter preservation during radical prostatectomy. , 2011, European urology.

[67]  S. Lipsitz,et al.  Cost implications of the rapid adoption of newer technologies for treating prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  M. Porter,et al.  What is value in health care? , 2010, The New England journal of medicine.

[69]  Jim Evans.  The current state of bundled payments. , 2010, American health & drug benefits.

[70]  C. Gross,et al.  Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology. , 2010, International journal of radiation oncology, biology, physics.

[71]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[72]  M. Porter,et al.  Value-based health care delivery. , 2008, Annals of Surgery.

[73]  E. Yano,et al.  Urologic diseases in America Project: analytical methods and principal findings. , 2005, The Journal of urology.

[74]  H M Sandler,et al.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. , 2000, Urology.